Results: 340

Use of a severity indicator as a predictor of the use of hepatic transplantation resources

Rev. Esc. Enferm. USP; 50 (4), 2016
Abstract OBJECTIVE To evaluate the use of a severity indicator for end-stage liver disease as a predictor of resource use in a teaching hospital in São Paulo. METHOD Descriptive, retrospective study, classifying independent variables in seven key dimensions: identification/risk rating; length of stay/...

Transplante de fígado em paciente com hepatocarcinoma fibrolamelar - relato de caso

O hepatocarcinoma fibrolamelar (HCC-FL), variante do hepatocarcinoma (HCC), é uma neoplasia rara, responsável por 0,6-8,6% das neoplasias de origem no hepatócito. O diagnóstico é feito através de exames de imagem e confirmado pelo exame anatomopatológico. O transplante de fígado (TF) apresenta-se...

Conductas de riesgo en adolescentes con patología crónica compleja bajo control en un policlínico de un hospital pediátrico de Santiago

Rev. méd. Chile; 144 (6), 2016
Adolescents with complex diseases may have a higher frequency of risk behaviors than their healthy peers. Aim: To characterize risk behaviors in adolescents with complex chronic diseases. Patients and Methods: Risk behaviors were assessed by means of a self-administered questionnaire designed for this pu...

Thrombin activatable fibrinolysis inhibitor como preditor de sangramento no transplante hepático: estudo piloto observacional

RESUMO Objetivo: Correlacionar os níveis de thrombin activatable fibrinolysis inhibitor no pós-operatório imediato e com 24 horas de pós-operatório com o volume de sangramento tansoperatório. Métodos: Foram analisados vinte e um pacientes alocados imediatamente antes do transplante hepático (...

Quality of life in liver transplant recipients and the influence of sociodemographic factors

Rev. Esc. Enferm. USP; 50 (3), 2016
Abstract OBJECTIVE To verify the influence of sociodemographic factors on the quality of life of patients after liver transplant. METHOD Cross-sectional study with 150 patients who underwent liver transplant at a referral center. A sociodemographic instrument and the Liver Disease Quality of Life que...

Trace elements in plasma and nutritional assessment in patients with compensated cirrhosis on a liver transplant list

Arq. gastroenterol; 53 (2), 2016
ABSTRACT Background - In chronic liver disease, trace element levels in plasma are usually low. However, the specific cause and functional implications of this abnormality are yet not well understood. These element levels may decrease as a result of abnormal liver function in patients with cirrhosis a...

Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders

Rev. argent. microbiol; 48 (2), 2016
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for e...

Análisis de costo efectivi dad de everolimus más tacrolimus y prednisolona comparado con tacrolimus más prednisolona para la inmunosupresión de mantenimiento en el trasplante hepático en Colombia
Cost-effectiveness analysis of everolimus plus tacrolimus and prednisolone compared to tacrolimus plus prednisolone for maintenance immunosuppression in liver transplantation in Colombia

Problema de investigación: Calcular los costos y la efectividad esperados del Everolimus más Tacrolimus (dosis reducida) y Corticosteroide (ETC) comparado con Tacrolimus (dosis estándar) más Corticoesteroide (TC) para el tratamiento de pacientes colombianos, adultos, receptores de trasplante de híga...

Análisis de impacto presupuestal de everolimus más tacrolimus y prednisolona comparado con tacrolimus y prednisolona para la profilaxis del rechazo en los receptores de trasplante de hígado en Colombia
Analysis of budget impact of everolimus plus tacrolimus and prednisolone compared to tacrolimus and prednisolone for rejection prophylaxis in liver transplant recipients in Colombia

Tecnologías evaluadas: Intervención: e verolimus más tacrolimus y corticoesteroide en pacientes con trasplante de hígado. Comparador: tacrolimus y prednisolona. Población: Adultos receptores trasplante de hígado por primera vez. Perspectiva: Tercer pagador, que en el caso colombiano corresponde al ...